Clinical Trial Technology That Accelerates Within Compliance.
Clinical trials are slow, expensive and heavily regulated — and technology can accelerate them, but only if it respects the compliance trials can't compromise on. We build clinical trial technology that speeds and de-risks the process — eConsent, EDC, decentralised and patient-facing systems — while meeting the rigorous regulatory standards that come first in trials.
Trials Are Slow and Regulated — Both Are Real
Clinical trials are notoriously slow and expensive, and they're also among the most heavily regulated activities there are — for good reason, since they involve human participants and produce the evidence that medical decisions rest on. Both realities are real and both matter: the slowness and cost are a genuine problem worth solving, and the regulatory rigour is non-negotiable, because compromising it endangers participants and invalidates results. Clinical trial technology has to hold both at once — accelerating trials without ever compromising the compliance that comes first.
This is the defining constraint of trial technology, and it's what makes it a specialised domain. eConsent, electronic data capture (EDC), decentralised trial capabilities and patient-facing systems can genuinely speed and de-risk trials — making participation easier, data cleaner, and processes faster — but every one of them operates in a regulated environment where data integrity, participant safety, auditability and regulatory standards are paramount. Technology that accelerates a trial by cutting compliance corners isn't a solution; it's a risk to participants and to the trial's validity. The discipline is delivering the acceleration within the rules, not around them.
We build clinical trial technology that accelerates within compliance. We build eConsent, EDC, decentralised and patient-facing systems that speed and de-risk trials while meeting the rigorous regulatory standards trials require. The point is faster trials without compromising compliance, which takes respecting both, and exactly what we provide.
What Our Clinical Trial Technology Delivers
Our Clinical Trial Technology Process
1. Respect the Regulation
We start from the regulatory standards trials can't compromise, building within them.
2. Find the Acceleration
We identify where technology can speed and de-risk the trial compliantly.
3. Build for Integrity
We build eConsent, EDC and patient systems with data integrity and auditability built in.
4. Ease Participation
We use decentralised and patient-facing tech to ease participation within the rules.
5. Accelerate Compliantly
We deliver faster, de-risked trials without ever cutting compliance corners.
Acceleration That Cuts Compliance Corners Is a Risk
The tempting but wrong way to speed up a trial is to cut compliance corners — and in clinical trials that's not a shortcut, it's a serious risk. Compromising data integrity, participant safety or auditability to move faster endangers the people in the trial and can invalidate the results the entire trial exists to produce, wasting the whole effort. In a domain this regulated and this consequential, acceleration that comes at the cost of compliance isn't acceleration at all; it's a failure waiting to be discovered, often at the worst possible moment.
Real acceleration comes from technology that speeds the process within the rules. eConsent that makes consent easier while fully meeting requirements; EDC that produces cleaner data faster while preserving integrity; decentralised capabilities that ease participation without compromising oversight. These genuinely accelerate and de-risk trials, but their value depends entirely on being built for the regulated environment — with data integrity, safety and auditability as foundations, not afterthoughts. The expertise is in delivering the speed within the compliance, which requires understanding both the technology and the regulatory domain deeply.
We build clinical trial technology that accelerates within compliance, never around it. By building eConsent, EDC, decentralised and patient systems with regulatory rigour as the foundation, we speed and de-risk trials without endangering participants or results. Acceleration within compliance is the point, and exactly what we deliver.
Accelerate Trials Without Compromising Compliance
Clinical trial technology has to accelerate within compliance, never around it — speed that cuts corners is a risk, not a solution. Delivering acceleration within the rules is exactly what we provide.
We build clinical trial technology that accelerates within compliance. By building eConsent, EDC and patient systems with regulatory rigour as the foundation, we speed and de-risk trials safely.
If trial technology speeds the process by cutting compliance corners, it endangers participants and results. We build clinical trial technology — eConsent, EDC, decentralised systems — that accelerates within the rigorous compliance trials require.
Frequently Asked Questions
Clinical trial technology is software for running clinical trials — eConsent, electronic data capture (EDC), decentralised trial capabilities, and patient-facing systems. Its defining challenge is accelerating and de-risking trials while meeting the rigorous regulatory standards trials require, because trials are both notoriously slow and heavily regulated, and both realities must be respected at once.
Yes — eConsent, EDC, decentralised capabilities and patient systems can genuinely speed and de-risk trials by easing participation, producing cleaner data faster, and streamlining processes. But the acceleration only counts if it's delivered within compliance, because speeding a trial by cutting regulatory corners endangers participants and can invalidate results, which isn't acceleration at all.
Because trials involve human participants and produce the evidence medical decisions rest on. Compromising data integrity, participant safety or auditability endangers people and can invalidate the results the entire trial exists to produce. The regulatory rigour exists for good reason, so technology must work within it — acceleration that cuts compliance corners is a serious risk, not a shortcut.
eConsent is electronic informed consent — letting trial participants give consent digitally rather than on paper. Done well, it's easier and clearer for participants while fully meeting regulatory requirements for informed consent. It's an example of trial technology that can speed and improve the process, but only when built to meet the strict regulatory standards consent involves.
EDC (electronic data capture) is technology for collecting and managing clinical trial data electronically rather than on paper. It can produce cleaner data faster and reduce errors, accelerating and de-risking the trial — but it must preserve data integrity and auditability, since trial data is the evidence the trial produces. Good EDC delivers speed and quality within those regulatory requirements.
Decentralised (or remote) trials use technology to let participants take part from where they are, rather than only at trial sites — easing participation and potentially speeding recruitment and reducing dropout. Done compliantly, they can de-risk and accelerate trials, but the remote elements must still meet regulatory standards for oversight, data integrity and participant safety, which is exactly the discipline trial technology requires.
Clinical trial technology sits within the broader life sciences and healthcare technology space, sharing the demand for regulatory rigour and data integrity. It connects to healthcare data analytics, pharma technology and more. The defining focus here is the trial process specifically — accelerating it within the compliance trials uniquely require, which is its specialised concern.
Ready to Get Started with Clinical Trial Technology?
150+ D2C brands scaled. $500 Mn+ in tracked revenue. Since 2004.